跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 743 条关于
“SURPASS”
全部
743
临床试验
38
药物
0
机构
2
资讯
703
3年前
Ropeginterferon Alfa-2b Shows Promise in Hydroxyurea-Resistant Essential Thrombocythemia
3年前
Margetuximab Fails to Show Overall Survival Benefit Over Trastuzumab in HER2-Positive Breast Cancer
11年前
Ropeginterferon Alfa-2b Evaluated as Second-Line Therapy for High-Risk Essential Thrombocythemia in SURPASS-ET Trial
3年前
Ropeginterferon Alfa-2b Shows Promise as Second-Line Treatment for High-Risk Essential Thrombocythemia
上个月
mRNA Synthesis Raw Materials Market to Surpass USD 3.89 Billion by 2035
3个月前
RedHill Biopharma Advances Opaganib for Bundibugyo Ebola Outbreak as Cases Surpass 3,200
9天前
Bangladesh measles deaths surpass 1,000 as vaccination drive falls short of herd immunity
3个月前
US Measles Cases Surpass 2,000 for Second Consecutive Year, Elimination Status at Risk
去年
Tirzepatide Shows Promising Renal Benefits in Type 2 Diabetes Patients Through SURPASS Trials Analysis
9个月前
Tirzepatide Shows Consistent Cardiovascular Benefits Regardless of Heart Failure Status in SURPASS-CVOT Trial
第 1 页,共 71 页
上一页
下一页